IRIS
CHIAPPINI, STEFANIA
 Distribuzione geografica
Salva come PNG Salva come JPEG
Continente #
NA - Nord America 1.389
AS - Asia 1.205
EU - Europa 686
SA - Sud America 420
AF - Africa 73
Continente sconosciuto - Info sul continente non disponibili 13
OC - Oceania 4
Totale 3.790
Salva come PNG Salva come JPEG
Nazione #
US - Stati Uniti d'America 1.244
IT - Italia 547
SG - Singapore 380
BR - Brasile 309
CN - Cina 232
HK - Hong Kong 161
BD - Bangladesh 98
VN - Vietnam 83
CA - Canada 59
IN - India 54
MX - Messico 48
AR - Argentina 36
IQ - Iraq 28
FR - Francia 27
PK - Pakistan 22
EC - Ecuador 20
GB - Regno Unito 19
ID - Indonesia 16
NL - Olanda 16
TR - Turchia 16
CO - Colombia 15
DE - Germania 15
PH - Filippine 15
UZ - Uzbekistan 15
ZA - Sudafrica 14
MY - Malesia 13
RU - Federazione Russa 13
VE - Venezuela 13
JO - Giordania 12
SA - Arabia Saudita 12
CL - Cile 11
MA - Marocco 10
TN - Tunisia 10
CR - Costa Rica 9
KE - Kenya 9
PL - Polonia 8
GT - Guatemala 7
LY - Libia 7
NP - Nepal 7
PY - Paraguay 7
AE - Emirati Arabi Uniti 6
AL - Albania 6
OM - Oman 6
UA - Ucraina 6
UY - Uruguay 6
EG - Egitto 5
JM - Giamaica 5
DZ - Algeria 4
ES - Italia 4
GH - Ghana 4
HN - Honduras 4
TH - Thailandia 4
AU - Australia 3
AZ - Azerbaigian 3
BM - Bermuda 3
ET - Etiopia 3
KZ - Kazakistan 3
RO - Romania 3
TT - Trinidad e Tobago 3
DK - Danimarca 2
FI - Finlandia 2
HR - Croazia 2
IE - Irlanda 2
IR - Iran 2
KG - Kirghizistan 2
KR - Corea 2
NG - Nigeria 2
PE - Perù 2
QA - Qatar 2
YE - Yemen 2
AD - Andorra 1
AF - Afghanistan, Repubblica islamica di 1
AM - Armenia 1
BA - Bosnia-Erzegovina 1
BB - Barbados 1
BE - Belgio 1
BH - Bahrain 1
BT - Bhutan 1
BW - Botswana 1
BY - Bielorussia 1
CU - Cuba 1
CZ - Repubblica Ceca 1
DO - Repubblica Dominicana 1
EE - Estonia 1
GE - Georgia 1
GF - Guiana Francese 1
GN - Guinea 1
GR - Grecia 1
HU - Ungheria 1
IL - Israele 1
JE - Jersey 1
LB - Libano 1
LT - Lituania 1
MK - Macedonia 1
ML - Mali 1
MZ - Mozambico 1
NZ - Nuova Zelanda 1
PA - Panama 1
PR - Porto Rico 1
PS - Palestinian Territory 1
Totale 3.770
Salva come PNG Salva come JPEG
Città #
San Jose 521
Ashburn 225
Singapore 215
Rome 185
Hong Kong 158
Beijing 126
Council Bluffs 99
Milan 46
Mexico City 42
Santa Clara 40
Ho Chi Minh City 29
Hanoi 23
Naples 22
Florence 16
Baghdad 14
São Paulo 14
Tashkent 13
New York 11
Amman 10
Buffalo 10
Los Angeles 10
Rio de Janeiro 10
Toronto 10
Atlanta 9
Karachi 9
Caracas 8
Frankfurt am Main 8
Quito 8
Brasília 7
Brescia 7
Nairobi 7
Palermo 7
Perugia 7
Porto Alegre 7
Belo Horizonte 6
Chicago 6
Dhaka 6
Guayaquil 6
Hamilton 6
Johannesburg 6
San José 6
Tripoli 6
Aci Catena 5
Casablanca 5
Catania 5
Delhi 5
Figino 5
Jeddah 5
Kaithal 5
Kuala Lumpur 5
Montreal 5
North Bergen 5
Pittsburgh 5
Ribeirão Preto 5
San Antonio 5
Turin 5
Accra 4
Benevento 4
Bologna 4
Brooklyn 4
Calgary 4
Cincinnati 4
Contagem 4
Cotia 4
Curitiba 4
Houston 4
Izmir 4
Kansas City 4
London 4
Manaus 4
Medellín 4
Montevideo 4
Mumbai 4
Muscat 4
Philadelphia 4
Queens 4
Riyadh 4
Salvador 4
Santiago 4
Tirana 4
Tunis 4
Addis Ababa 3
Alexandria 3
Ankara 3
Baku 3
Baltimore 3
Betim 3
Bucharest 3
Cairo 3
Chula Vista 3
Da Nang 3
Dallas 3
Decatur 3
Duque de Caxias 3
El Paso 3
Fort Collins 3
Fortaleza 3
Guarujá 3
Guarulhos 3
Guatemala City 3
Totale 2.208
Salva come PNG Salva come JPEG
Nome #
Understanding the use of prescription and OTC drugs in obtaining highs and the pharmacist role in preventing abuse 190
Knowledge and use of over-the-counter drugs in Italy: an exploratory survey-based study in the general population 91
Evaluating craving in Alcohol Use Disorder: psychometric characteristics of the Craving Typology Questionnaire-15 (CTQ-15) 73
Le nuove sostanze psicoattive 62
'New/Designer Benzodiazepines': An Analysis of the Literature and Psychonauts' Trip Reports 59
Focus on Over-the-Counter Drugs' Misuse: A Systematic Review on Antihistamines, Cough Medicines, and Decongestants 59
A Focus on Abuse/Misuse and Withdrawal Issues with Selective Serotonin Reuptake Inhibitors (SSRIs): Analysis of Both the European EMA and the US FAERS Pharmacovigilance Databases 58
Nuove frontiere nell'abuso di sostanze, psiconauti e internet 57
Real-world experience of esketamine use to manage treatment-resistant depression: A multicentric study on safety and effectiveness (REAL-ESK study) 57
New psychoactive substances and suicidality: A systematic review of the current literature 51
Atypical Antipsychotic Drugs in Dual Disorders: Current Evidence for Clinical Practice 50
Are finasteride-related penile curvature/Peyronie's disease Adverse Event Reports worthy of further clinical investigation? Disproportionality analysis based on both the Food and Drug Administration (FDA) and the European Medicines Agency (EMA) pharmacovigilance databases 50
Therapeutic Potentials of Ketamine and Esketamine in Obsessive-Compulsive Disorder (OCD), Substance Use Disorders (SUD) and Eating Disorders (ED): A Review of the Current Literature 49
New psychoactive substances (NPS) and serotonin syndrome onset: A systematic review 48
2876 – Glutamatergic strategies in the treatment of pathological gambling: a pilot study 47
The rapid antidepressant effectiveness of repeated dose of intravenous ketamine and intranasal esketamine: A post-hoc analysis of pooled real-world data 46
Duration of untreated disorder and cannabis use: An observational study on a cohort of young italian patients experiencing psychotic experiences and dissociative symptoms 45
A multidisciplinary approach for addiction treatment in an Italian day hospital service: a therapy model and its goals 44
A Focus on Abuse/Misuse and Withdrawal Issues with Selective Serotonin Reuptake Inhibitors (SSRIs): An Analysis of Pharmacovigilance Databases 44
Utilizzo del pregabalin nel trattamento del gioco d'azzardo patologico: dati preliminari 44
Assessing The 2004-2018 Fentanyl Misusing Issues Reported To An International Range Of Adverse Reporting Systems 43
The e-psychonaut drugs' psychopharmacology 43
Is There a Risk for Semaglutide Misuse? Focus on the Food and Drug Administration's FDA Adverse Events Reporting System (FAERS) Pharmacovigilance Dataset 43
Beyond the purple drank. Study of promethazine abuse according to the Eurovigilance dataset 43
Brexpiprazole as a new approach of treatment in somatization disorder 43
A decade of gabapentinoid misuse: an analysis of the European Medicines Agency's ‘suspected adverse drug reactions' database. Assessment of gabapentinoid misuse/dependence as reported to the EMA 42
‘Z-trip'? A comprehensive overview and and a case-series of Zolpidem misuse 42
Relationship between impulsivity, mood disorders and personality traits in a sample of pathological gamblers 42
Is medicinal ketamine associated with urinary dysfunction issues? Assessment of both the European Medicines Agency (EMA) and the UK Yellow Card Scheme pharmacovigilance database-related reports 40
Misuse of Anticholinergic Medications: A Systematic Review 40
Beyond the ‘purple drank’. Study of promethazine abuse according to the European Medicines Agency (EMA) Adverse Drug Reactions (ADR) reports 40
ARE Z-DRUGS SAFE? STUDY OF THEIR MISUSE, ABUSE AND DEPENDENCE ACCORDING TO THE EUROPEAN MEDICINES AGENCY (EMA) PHARMACOVIGILANCE DATABASE. 40
Recreational Drug Misuse and Its Potential Contribution to Male Fertility Levels' Decline: A Narrative Review 40
What about “pharming”? Issues regarding the misuse of prescription and over-the-counter drugs 39
High-Risk Gaming Is Associated with Frequent Substance Use: An Exploratory Survey among Young Adults 39
Opioid painkiller dependence in a sample of elderly medical inpatients 39
Gestione dei pazienti con depressione resistente al trattamento in comorbilità con il disturbo da uso di sostanze: sicurezza ed efficacia dell'esketamina in un sottocampione di pazienti dello studio REAL-ESK 39
Addiction: a therapeutic model for the restructuring of identity 39
Aripiprazole once monthly as a maintenance treatment for patients with schizophrenia and alcohol/substance use disorder: an observational, real-world study 39
Climate change, biodiversity loss and mental health: a global perspective 39
Abuse of Prescription Drugs in the Context of Novel Psychoactive Substances (NPS): A Systematic Review 38
Esketamine in treatment-resistant depression patients comorbid with substance-use disorder: A viewpoint on its safety and effectiveness in a subsample of patients from the REAL-ESK study 38
Behavioural changes in cocaine dependent patients after group-therapy 38
Fatalities Associated with Mephedrone in Combination with Other Stimulant Drugs in Young People Aged 16-24 Years 38
Age in Pathological Gambling: Correlations with Personality and Psychiatric Comorbidity. 38
Methoxetamine: An Analogue of Ketamine 37
Evaluation of an italian sample of gamblers with dannon ainhold gambling scale: preliminary study 37
New/emerging psychoactive substances and associated psychopathological consequences. 37
Nationwide consensus on the clinical management of treatment-resistant depression in Italy: a Delphi panel 37
Ibogaine/Noribogaine in the treatment of Substance Use Disorders: a systematic review and Meta-analysis of side effects 36
Treating bipolar depression with esketamine: Safety and effectiveness data from a naturalistic multicentric study on esketamine in bipolar versus unipolar treatment-resistant depression 36
How does ayahuasca work from a psychiatric perspective? Pros and cons of the entheogenic therapy 35
Investigating the Effectiveness and Tolerability of Intranasal Esketamine Among Older Adults With Treatment-Resistant Depression (TRD): A Post-hoc Analysis from the REAL-ESK Study Group 35
Validation of a diagnostic questionnaire based on DSM-IV criteria for gambling. 35
Pregabalin treatment in pathological gambling: a preliminary study 35
Exploring the nexus of binge eating disorder (BED), New Psychoactive Substances (NPS), and misuse of pharmaceuticals: charting a path forward 35
Loperamide diversion and abuse: assessment of its non-medical use through the analysis of loperamide-related European Medicines Agency (EMA) pharmacovigilance database reports 35
Substance-Use Disorders and Violence 35
Use of Medicinal Cannabis and Synthetic Cannabinoids in Post-Traumatic Stress Disorder (PTSD): A Systematic Review. 34
Club Drugs and Psychiatric Sequelae: An Issue of Vulnerability and Previous Psychiatric History 34
Pharmacovigilance signals of the opioid epidemic over 10 years: an analysis of pharmacovigilance datasets collecting Adverse Drug Reactions (ADRs) reported to EudraVigilance (EV) and the FDA Adverse Event Reporting System (FAERS) 34
The role of novel psychoactive substances (NPS) in mental health care of young people: a systematic review 34
There is a potential of misuse for venlafaxine and bupropion? 34
COVID-19: The hidden impact on mental health and drug addiction 34
β-2 agonists as misusing Drugs? Assessment of both Clenbuterol- and Salbutamol-related European Medicines Agency (EMA) Pharmacovigilance Database Reports. 33
Mobile phone use during adolescence: a new addiction? 33
The benzydamine experience: a systematic review of benzydamine abuse 33
Psychobiological, medical, and psychiatric implications of new/novel psychoactive substance (NPS) use 33
Editorial: Prescribing Psychotropics: Misuse, Abuse, Dependence, Withdrawal and Addiction 33
Is there a potential of misuse for quetiapine? Literature review and analysis of the European Medicines Agency/EMA Adverse Drug Reactions' database 33
The bridge between classical and ‘synthetic'/chemical psychoses: towards a clinical, psychopathological and therapeutic perspective 32
Cannabidiol (CBD) Use in Psychiatric Disorders: a Systematic Review 32
Efficacy of psychosocial and psychological interventions in addition to drug therapy to improve global functioning of inpatients with schizophrenia spectrum and mood disorders: a real-world observational study 32
The opioid epidemic over the past 10 years: pharmacovigilance signals from the European Medicines Agency (EMA) and the FDA Adverse Event Reporting System (FAERS) 32
Psychopathologic aspects of obesity: Psychodiagnostic evaluations of bariatric surgery applicants 32
Alprazolam-related deaths in Scotland, 2004-2020 31
The Unregulated Psychoactive Compound: ‘Benzo Fury' 31
Compulsiveness dimension in a case of pathological gambling 31
Psychosocial risk factors for postpartum depression: a descriptive sample of pregnants 31
Behavioural Addictions In Adolescence: Findings From An Italian Survey 30
Pregabalin: a range of misuse-related unanswered questions 29
Efficacy of Noninvasive Brain Stimulation on Borderline Personality Disorder Core Symptoms: A Systematic Review 29
NPS stimulants 29
Special M related fatalities in the UK. 28
New psychoactive substances (NPS), psychedelic experiences, and dissociation; clinical and clinical pharmacological issues. 28
The misuse of prescription drugs in the digital era: pros and cons 28
An Update on Psychoactive Substances: Pharmacology and Toxicology Issues 28
Online Gambling, Impulsivity and Personality Traits: an Italian Sample 28
An insight into Z-drugs abuse and dependence: an examination of reports to the European Medicines Agency (EMA) database of suspected Adverse Drug Reactions (ADR) 27
Misuse and Abuse of Prescription Drugs in Custodial Settings 27
Is there such a thing as a 'lope' dope? Analysis of loperamide-related European Medicines Agency (EMA) pharmacovigilance database reports 26
Focus on Clozapine Withdrawal- and Misuse-Related Cases as Reported to the European Medicines Agency (EMA) Pharmacovigilance Database 25
To bridge or not to bridge: Moral Judgement in Cocaine Use Disorders, a case-control study on human morality. 25
Cannabis: evidenze epidemiologiche, cliniche e terapeutiche 24
Totale 3.790
Salva come PNG Salva come JPEG
Categoria #
all - tutte 16.627
article - articoli 0
book - libri 0
conference - conferenze 0
curatela - curatele 0
other - altro 0
patent - brevetti 0
selected - selezionate 0
volume - volumi 0
Totale 16.627
Salva come PNG Salva come JPEG


Totale Lug Ago Sett Ott Nov Dic Gen Feb Mar Apr Mag Giu
2023/20241 0 0 0 0 0 0 0 0 0 0 0 1
2024/2025777 21 99 3 0 22 12 61 128 56 38 188 149
2025/20262.339 122 25 154 158 243 169 191 111 573 304 144 145
2026/2027673 81 34 246 312 0 0 0 0 0 0 0 0
Totale 3.790